Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

NCT04773678 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

322

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Persistent Asthma

Interventions

DRUG: CBP-201
DRUG: Placebo

Sponsor

Connect Biopharm LLC